Tetracycline Treatment Retards the Onset and Slows the Progression of Diabetes in Human Amylin/Islet Amyloid Polypeptide Transgenic Mice
Tetracycline Treatment Retards the Onset and Slows the Progression of Diabetes in Human Amylin/Islet Amyloid Polypeptide Transgenic Mice Jacqueline F. Aitken 1 , 2 , Kerry M. Loomes 1 , 2 , David W. Scott 1 , 3 , Shivanand Reddy 1 , Anthony R.J. Phillips 1 , 2 , 4 , Gordana Prijic 1 , Chathurini Fer...
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2010-01, Vol.59 (1), p.161-171 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Tetracycline Treatment Retards the Onset and Slows the Progression of Diabetes in Human Amylin/Islet Amyloid Polypeptide Transgenic
Mice
Jacqueline F. Aitken 1 , 2 ,
Kerry M. Loomes 1 , 2 ,
David W. Scott 1 , 3 ,
Shivanand Reddy 1 ,
Anthony R.J. Phillips 1 , 2 , 4 ,
Gordana Prijic 1 ,
Chathurini Fernando 1 ,
Shaoping Zhang 1 , 2 ,
Ric Broadhurst 5 ,
Phil L'Huillier 5 and
Garth J.S. Cooper 1 , 2 , 3 , 6
1 School of Biological Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;
2 Maurice Wilkins Centre for Molecular Biodiscovery, Faculty of Science, University of Auckland, Auckland, New Zealand;
3 Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;
4 Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;
5 AgResearch, Ruakura, Hamilton, New Zealand;
6 Department of Pharmacology, Medical Sciences Division, University of Oxford, Oxford, U.K.
Corresponding author: Garth J.S. Cooper, g.cooper{at}auckland.ac.nz .
J.F.A., K.M.L., and D.W.S. contributed equally to this article.
Abstract
OBJECTIVE Aggregation of human amylin/islet amyloid polypeptide (hA/hIAPP) into small soluble β-sheet–containing oligomers is linked
to islet β-cell degeneration and the pathogenesis of type 2 diabetes. Here, we used tetracycline, which modifies hA/hIAPP
oligomerization, to probe mechanisms whereby hA/hIAPP causes diabetes in hemizygous hA/hIAPP-transgenic mice.
RESEARCH DESIGN AND METHODS We chronically treated hemizygous hA/hIAPP transgenic mice with oral tetracycline to determine its effects on rates of diabetes
initiation, progression, and survival.
RESULTS Homozygous mice developed severe spontaneous diabetes due to islet β-cell loss. Hemizygous transgenic animals also developed
spontaneous diabetes, although severity was less and progression rates slower. Pathogenesis was characterized by initial islet
β-cell dysfunction followed by progressive β-cell loss. Islet amyloid was absent from hemizygous animals with early-onset
diabetes and correlated positively with longevity. Some long-lived nondiabetic hemizygous animals also had large islet-amyloid
areas, showing that amyloid itself was not intrinsically cytotoxic. Administration of tetracycline dose-dependently ameliorated
hyperglycemia and polydipsia, delayed rates of diabetes initiation and progression, and increased longevity compared with
water-treated controls.
CONCL |
---|---|
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/db09-0548 |